Zobrazeno 1 - 6
of 6
pro vyhledávání: '"JTD Souto-Filho"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S519-S520 (2024)
Introduction: The advent of novel therapeutic agents has markedly improved outcomes for patients with multiple myeloma (MM). The phase 2 GRIFFIN and phase 3 PERSEUS studies have demonstrated that adding daratumumab to VRD induction and consolidation
Externí odkaz:
https://doaj.org/article/0b9bf7d8bf0f47a4b3e202f4f2648fa7
Autor:
CS Chiattone, E Miranda, SS Medina, RLR Baptista, J Pereira, SAB Brasil, JV Tavares, KZ Cecyn, FL Nogueira, M Bellosso, DFC Farias, D Borducchi, NS Castro, S Nabhan, PPG Rakde, CCG Macedo, CC Vilarim, M Dias, E Negreiros, VLP Figueiredo, DV Clé, R Schaffel, RD Gaiolla, S Schusterschitz, T Fischer, GF Silva, Y Gonzaga, N Zing, AD Cunha-Jr, JTD Souto-Filho, S Mo, EFO Ribeiro, FB Duarte, RR Sousa, MAL Matedi, MD Pont, N Hamerschlak, G Perini, YS Rabelo, ND Bueno, P Cury, A Hallack-Neto, MT Delamain, M Federico, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S332-S333 (2023)
Objectives: T-cell Brazil project started in April 2017 focusing to collecting epidemiological and clinical data from the most frequent subtypes of PTCL, as an ambispective study collected diagnosis data from January 2015 to December 2022. Our goals
Externí odkaz:
https://doaj.org/article/34934cf181a7482799c281eb9e495689
Autor:
CS Chiattone, MT Delamain, ECM Miranda, J Pereira, DLC Farias, S Nabhan, M Bellesso, N Hamerschlak, N Zing, N Castro, G Ribeiro, RLR Baptista, Y Gonzaga, R Gaiolla, A Cordeiro, R Schaffel, JTD Souto-Filho, E Negreiros, A Hallack-Neto, EFO Ribeiro, CC Vilarim, CCG Macedo, SAB Brasil, SKG Mo, AD Cunha-Junior, P Cury, KZ Cecyn, G Duffles, M Federico, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S96-S97 (2021)
Introdução: O papel da terapia de altas doses (TAD) seguida pelo transplante de células tronco periférico (TCTP) autólogo como consolidação é ainda muito discutido para os pacientes com Linfoma de células T periféricas (LCTP), ou seja, não
Externí odkaz:
https://doaj.org/article/2e9d05da5077474a9735646a17549ac8
Autor:
CS Chiattone, E Miranda, J Pereira, KZ Cecyn, NS Castro, SAB Brasil, DFC Farias, M Bellesso, G Duffles, D Borducchi, Y Gonzaga, RLR Baptista, CC Vilarim, CCG Macedo, M Dias, MA Salvino, JV Tavares, S Nabhan, AD Cunha-Junior, N Zing, GF Silva, GN Ribeiro, E Negreiros, R Schaffel, VLP Figueiredo, JTD Souto-Filho, PPG Radtke, MD Pont, FL Nogueira, N Hamerschlak, DV Cle, R Gaiolla, FB Duarte, RR Souza, S Mo, A Hallack-Neto, YS Rabelo, EFO Ribeiro, A Cordeiro, G Perini, ND Bueno, MAL Matedi, P Cury, MT Delamain, M Federico, CA Souza
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S91-S92
Autor:
Natalia Pin Chuen Zing, Sab Brasil, Rony Schaffel, Karin Zattar Cecyn, C.C. Vilarim, Massimo Federico, Marcia Torresan Delamain, Guilherme Duffles, Y. Gonzaga, N. Castro, Samir Kanaan Nabhan, Dlc Farias, E A Miranda, P. Cury, Jtd Souto-Filho, Carmino Antonio De Souza, Juliana Pereira, A. Hallack-Neto, Skg Mo, Marcelo Bellesso, Glaciano Ribeiro, A Cordeiro, Efo Ribeiro, Rlr Baptista, E Negreiros, C.S. Chiattone, Ccg Macedo, Nelson Hamerschlak, A.D. Cunha-Junior, Rafael Dezen Gaiolla
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S96-S97 (2021)
Introdução: O papel da terapia de altas doses (TAD) seguida pelo transplante de células tronco periférico (TCTP) autólogo como consolidação é ainda muito discutido para os pacientes com Linfoma de células T periféricas (LCTP), ou seja, não
Publikováno v:
Hematology Week; 11/6/2023, p938-938, 1p